Cytosolic nucleic acid sensing and mitochondrial transcriptomic changes as early triggers of metabolic disease in db/db miceAgnieszka H. Ludwig‐Słomczyńska, Paweł Wołkow|Mammalian Genome|2023Cited by 1
Abstract 4231: Preclinical candidate RVU305, an MTA-cooperative PRMT5 inhibitor, shows activity in MTAP-deleted tumors resistant to immune checkpoint treatmentAnna Bartosik, Krzysztof Brzózka, Aneta Bobowska et al.|Cancer Research|2025Cited by 1